Highland Park, IL, United States of America

Phil Bauer

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Phil Bauer: Innovator in Diabetic Neuropathy Treatment

Introduction

Phil Bauer is a notable inventor based in Highland Park, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of painful diabetic peripheral neuropathy (DPN). His innovative approach aims to improve the quality of life for patients suffering from this debilitating condition.

Latest Patents

Phil Bauer holds a patent for "Methods of treating painful diabetic peripheral neuropathy." This patent outlines methods for treating advanced painful DPN by administering an effective amount of NYX-2925 or a pharmaceutically acceptable salt thereof. Additionally, the patent includes crystalline forms of 3-hydroxy-2-(5-isobutyryl-1-oxo-2,5-diazaspiro[3,4]octan-2-yl)butanamide, showcasing his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Phil has demonstrated a strong dedication to research and innovation. His work at Tenacia Biotechnology (Hong Kong) Co., Limited has positioned him at the forefront of developing new therapies for chronic pain conditions. His expertise and innovative mindset have led to significant advancements in the field.

Collaborations

Phil Bauer collaborates with talented professionals in his field, including M Amin Khan and Mohsen Arghavani. These partnerships enhance the research and development process, allowing for a more comprehensive approach to tackling complex medical challenges.

Conclusion

Phil Bauer's contributions to the treatment of painful diabetic peripheral neuropathy highlight his role as an influential inventor in the medical field. His innovative methods and dedication to improving patient outcomes are commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…